Beneficial effects of thoracic epidural anaesthesia on mortality after surgery for colon cancer

ISRCTN ISRCTN10994336
DOI https://doi.org/10.1186/ISRCTN10994336
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number MarienVEC_12
Sponsor Marienhospital Vechta gGmbH
Funder Investigator initiated and funded
Submission date
25/05/2019
Registration date
07/06/2019
Last edited
29/08/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Perioperative use of epidural analgesia reduces the 36-month postoperative mortality rate. This effect may be due to systemic effects of local anaesthetics or to a reduced stress response caused by the thoracic epidural analgesia itself.

Who can participate?
Patients scheduled to undergo elective open colon cancer surgery.

What does the study involve?
Patients records are followed up over a 4 year period following surgery.

What are the possible benefits and risks of participating?
None.

Where is the study run from?
Marienhospital Vechta gGmbH, Germany.

When is the study starting and how long is it expected to run for?
January 1997 to December 2015

Who is funding the study?
The study is funded by the investigator.

Who is the main contact?
Dr Christian Hönemann,
c.honemann@icloud.com

Contact information

Dr Christian Hönemann
Scientific

arienstraße 6-8
Vechta
49377
Germany

ORCiD logoORCID ID 0000-0002-9658-253X
Phone +4915208961106
Email christian.hoenemann@kh-vec.de

Study information

Primary study designObservational
Study designObservational study
Secondary study designCohort study
Study type Participant information sheet
Scientific titleEpidural anaesthesia reduces mortality after colon cancer surgery
Study acronymEARMAC
Study objectivesEpidural anaesthesia reduces mortality after colon cancer surgery
Ethics approval(s)Approved DATE, Ethikkommission der Aerztekammer Niedersachsen (Ethical Committee of the Aerztekammer Niedersachsen, ÄKN Ethikkommission, Berliner Allee 20, 30175 Hannover, Germany; 05113802208; ethikkommission@aekn.de), ref:
Health condition(s) or problem(s) studiedPatients with elective colon cancer surgery
InterventionPatient records were used to follow-up on outcomes over 4 years for patients who had undergone elective colon cancer surgery with or without thoracic epidural anesthesia/analgesia.
Intervention typeOther
Primary outcome measure(s)

Mortality, measured by review of patient charts and a database of a local cancer database in Oldenburg, Germany

Key secondary outcome measure(s)

1. Perioperative complications
2. Stroke
3. Myocardial infarction
4. Blood transfusion
5. Duration of stay
All measured by review of patient charts and a database of a local cancer database in Oldenburg, Germany

Completion date31/12/2015

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration240
Key inclusion criteriaScheduled to undergo elective open colon cancer surgery
Key exclusion criteria1. Non elective surgery
2. Laparoscopic surgery
Date of first enrolment01/01/1997
Date of final enrolment31/12/2007

Locations

Countries of recruitment

  • Germany

Study participating centre

Marienhospital Vechta gGmbH
Marienstraße 6-8
Vechhta
49377
Germany

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
IPD sharing planThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

29/08/2019: Internal review.
06/06/2019: Trial’s existence confirmed by Aerztekammer Niedersachsen.